{"abstract": "The $2.375 billion deal may be a harbinger amid speculation that Pfizer will sell or spin off its nonpharmaceutical businesses.", "web_url": "https://dealbook.nytimes.com/2011/04/04/pfizer-sells-capsule-unit-to-k-k-r/", "snippet": "The $2.375 billion deal may be a harbinger amid speculation that Pfizer will sell or spin off its nonpharmaceutical businesses.", "lead_paragraph": "Pfizer said on Monday that it had agreed to sell its Capsugel unit, which makes a variety of capsules for drugs, to Kohlberg Kravis Roberts & Company for $2.375 billion in cash. ", "source": "The New York Times", "multimedia": [], "headline": {"main": "Pfizer Sells Capsule Unit to K.K.R.", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Kohlberg Kravis Roberts & Co", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 3, "major": "N"}], "pub_date": "2011-04-04T12:01:21+0000", "document_type": "article", "news_desk": "", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/958c5c8c-de5a-55ce-9d45-a444a58353f5", "word_count": 227, "uri": "nyt://article/958c5c8c-de5a-55ce-9d45-a444a58353f5"}